John M. Healey

Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA.

FlowMetric, Inc. provides flow cytometry and cell sorting services. It serves partners in multiple fields including biotechnology, small and large cap pharmaceuticals, hospitals and academic institutions. The firm provides flow cytometry, pre-clinical, pre-clinical toxicology and safety, clinical, cell sorting, monoclonal antibody production, and agri-food services. The company was founded by Renold Capocasale in 2010 and is headquartered in Doylestown, PA.